Difference gel electrophoresis DIGE
Proteomics offers powerful technologies to assist in the discovery of targets for novel therapeutic agents, by allowing the investigation of changes in protein state between control and diseased tissue and biofluids. Difference gel electrophoresis coupled with mass spectrometry (DIGE/MS) is a techno...
Gespeichert in:
| Veröffentlicht in: | Drug discovery today. Technologies 2006, Vol.3 (3), p.347-353 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 353 |
|---|---|
| container_issue | 3 |
| container_start_page | 347 |
| container_title | Drug discovery today. Technologies |
| container_volume | 3 |
| creator | Lilley, Kathryn S Friedman, David B |
| description | Proteomics offers powerful technologies to assist in the discovery of targets for novel therapeutic agents, by allowing the investigation of changes in protein state between control and diseased tissue and biofluids. Difference gel electrophoresis coupled with mass spectrometry (DIGE/MS) is a technology used within proteomics that has demonstrated technical robustness and associated statistical confidence to enable successful identification of therapeutic targets.
Anne-Claude Gavin – EMBL, Heidelberg, Germany
Albert Heck – Utrecht University, Utrecht, The Netherlands |
| doi_str_mv | 10.1016/j.ddtec.2006.09.013 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1542295838</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1740674906000618</els_id><sourcerecordid>1542295838</sourcerecordid><originalsourceid>FETCH-LOGICAL-c274t-f550c5e4f5b7051eaf87f733d5c3b11599b93ec93a1d8a25b9365f4d328309593</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-AkEKXrwkzn4l2YMHaWstFLzoeUl2Z3VL2sTdVPDfm9oqnjzNDDzvDPMQckkhpUCz21VqbYcmZQBZCioFyo_IkOYCkiwX6vhPPyBnMa4AuFC8OCUDJlQBkqshuZ565zDgxuD4Fesx1mi60LRvTcDo43i6mM_OyYkr64gXhzoiLw-z58ljsnyaLyb3y8SwXHSJkxKMROFklYOkWLoidznnVhpeUSqVqhRHo3hJbVEy2U-ZdMJyVnBQUvERudnvbUPzvsXY6bWPBuu63GCzjZpKwZiSBS96lO9RE5oYAzrdBr8uw6emoHd29Ep_29E7OxqU7u30qavDgW21Rvub-dHRA3d7APs3PzwGHY3fubE-9F60bfy_B74AjLl0Pg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1542295838</pqid></control><display><type>article</type><title>Difference gel electrophoresis DIGE</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Lilley, Kathryn S ; Friedman, David B</creator><creatorcontrib>Lilley, Kathryn S ; Friedman, David B</creatorcontrib><description>Proteomics offers powerful technologies to assist in the discovery of targets for novel therapeutic agents, by allowing the investigation of changes in protein state between control and diseased tissue and biofluids. Difference gel electrophoresis coupled with mass spectrometry (DIGE/MS) is a technology used within proteomics that has demonstrated technical robustness and associated statistical confidence to enable successful identification of therapeutic targets.
Anne-Claude Gavin – EMBL, Heidelberg, Germany
Albert Heck – Utrecht University, Utrecht, The Netherlands</description><identifier>ISSN: 1740-6749</identifier><identifier>EISSN: 1740-6749</identifier><identifier>DOI: 10.1016/j.ddtec.2006.09.013</identifier><identifier>PMID: 24980539</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Drug discovery today. Technologies, 2006, Vol.3 (3), p.347-353</ispartof><rights>2006 Elsevier Ltd</rights><rights>2006 Elsevier Ltd . All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c274t-f550c5e4f5b7051eaf87f733d5c3b11599b93ec93a1d8a25b9365f4d328309593</citedby><cites>FETCH-LOGICAL-c274t-f550c5e4f5b7051eaf87f733d5c3b11599b93ec93a1d8a25b9365f4d328309593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ddtec.2006.09.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24980539$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lilley, Kathryn S</creatorcontrib><creatorcontrib>Friedman, David B</creatorcontrib><title>Difference gel electrophoresis DIGE</title><title>Drug discovery today. Technologies</title><addtitle>Drug Discov Today Technol</addtitle><description>Proteomics offers powerful technologies to assist in the discovery of targets for novel therapeutic agents, by allowing the investigation of changes in protein state between control and diseased tissue and biofluids. Difference gel electrophoresis coupled with mass spectrometry (DIGE/MS) is a technology used within proteomics that has demonstrated technical robustness and associated statistical confidence to enable successful identification of therapeutic targets.
Anne-Claude Gavin – EMBL, Heidelberg, Germany
Albert Heck – Utrecht University, Utrecht, The Netherlands</description><issn>1740-6749</issn><issn>1740-6749</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Lw0AQhhdRbK3-AkEKXrwkzn4l2YMHaWstFLzoeUl2Z3VL2sTdVPDfm9oqnjzNDDzvDPMQckkhpUCz21VqbYcmZQBZCioFyo_IkOYCkiwX6vhPPyBnMa4AuFC8OCUDJlQBkqshuZ565zDgxuD4Fesx1mi60LRvTcDo43i6mM_OyYkr64gXhzoiLw-z58ljsnyaLyb3y8SwXHSJkxKMROFklYOkWLoidznnVhpeUSqVqhRHo3hJbVEy2U-ZdMJyVnBQUvERudnvbUPzvsXY6bWPBuu63GCzjZpKwZiSBS96lO9RE5oYAzrdBr8uw6emoHd29Ep_29E7OxqU7u30qavDgW21Rvub-dHRA3d7APs3PzwGHY3fubE-9F60bfy_B74AjLl0Pg</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Lilley, Kathryn S</creator><creator>Friedman, David B</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2006</creationdate><title>Difference gel electrophoresis DIGE</title><author>Lilley, Kathryn S ; Friedman, David B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c274t-f550c5e4f5b7051eaf87f733d5c3b11599b93ec93a1d8a25b9365f4d328309593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lilley, Kathryn S</creatorcontrib><creatorcontrib>Friedman, David B</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today. Technologies</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lilley, Kathryn S</au><au>Friedman, David B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Difference gel electrophoresis DIGE</atitle><jtitle>Drug discovery today. Technologies</jtitle><addtitle>Drug Discov Today Technol</addtitle><date>2006</date><risdate>2006</risdate><volume>3</volume><issue>3</issue><spage>347</spage><epage>353</epage><pages>347-353</pages><issn>1740-6749</issn><eissn>1740-6749</eissn><abstract>Proteomics offers powerful technologies to assist in the discovery of targets for novel therapeutic agents, by allowing the investigation of changes in protein state between control and diseased tissue and biofluids. Difference gel electrophoresis coupled with mass spectrometry (DIGE/MS) is a technology used within proteomics that has demonstrated technical robustness and associated statistical confidence to enable successful identification of therapeutic targets.
Anne-Claude Gavin – EMBL, Heidelberg, Germany
Albert Heck – Utrecht University, Utrecht, The Netherlands</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>24980539</pmid><doi>10.1016/j.ddtec.2006.09.013</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1740-6749 |
| ispartof | Drug discovery today. Technologies, 2006, Vol.3 (3), p.347-353 |
| issn | 1740-6749 1740-6749 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1542295838 |
| source | ScienceDirect Journals (5 years ago - present) |
| title | Difference gel electrophoresis DIGE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A16%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Difference%20gel%20electrophoresis%20DIGE&rft.jtitle=Drug%20discovery%20today.%20Technologies&rft.au=Lilley,%20Kathryn%20S&rft.date=2006&rft.volume=3&rft.issue=3&rft.spage=347&rft.epage=353&rft.pages=347-353&rft.issn=1740-6749&rft.eissn=1740-6749&rft_id=info:doi/10.1016/j.ddtec.2006.09.013&rft_dat=%3Cproquest_cross%3E1542295838%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1542295838&rft_id=info:pmid/24980539&rft_els_id=S1740674906000618&rfr_iscdi=true |